Proteins involved in Francisella tularensis survival and replication inside macrophages

Future Microbiology

Volumn 7, Issue 11, 2012, Pages 1255-1268

  Ramond, Elodie ^a,b   Gesbert, Gael ^a,b   Barel, Monique ^a,b   Charbit, Alain ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

bacterial pathogen; Francisella tularensis; intracellular survival; protein secretion systems; virulence

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE ACPA; BACTERIAL PROTEIN; CARRIER PROTEIN; ENVELOPE PROTEIN; FERRIC UPTAKE REGULATOR; GLUTAMIC ACID; IRON; OUTER MEMBRANE PROTEIN; POLY GAMMA GLUTAMATE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADAPTATION; BACTERIAL METABOLISM; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL DEATH; CELL TYPE; CYTOPLASM; FRANCISELLA TULARENSIS; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; IRON TRANSPORT; MACROPHAGE; MEMBRANE VESICLE; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; TULAREMIA; TYPE I SECRETION SYSTEM; TYPE II SECRETION SYSTEM; TYPE III SECRETION SYSTEM; TYPE IV SECRETION SYSTEM;

BACTERIAL PROTEINS; CYTOSOL; FRANCISELLA TULARENSIS; HUMANS; MACROPHAGES; TULAREMIA; VIRULENCE FACTORS;

EID: 84867706641     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.103     Document Type: Review

References (114)

1. Francisella tularensis and Tularemia. Sjostedt A (Ed.). Fontiers Media SA, Switzerland (2011
2. Keim P, Johansson A, Wagner DM. Molecular epidemiolgy, evolution, and ecology of Francisella. Ann. NY Acad. Sci. 1105, 30-66 (2007).
3. McLendon MK, Apicella MA, Allen LA. Francisella tularensis: Taxonomy, genetics, and immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60, 167-185 (2006).
4. Johansson A, Petersen JM. Genotyping of Francisella tularensis, the causative agent of tularemia. J. AOAC Int. 93, 1930-1943 (2010).
5. Gallagher LA, Ramage E, Jacobs MA et al. A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl Acad. Sci. USA 104, 1009-1014 (2007).
6. Chong A, Celli J. The Francisella intracellular life cycle: Toward molecular mechanisms of intracellular survival and proliferation. Front. Microbiol. 1, 138 (2010).
7. Ray K, Marteyn B, Sansonetti PJ, Tang CM. Life on the inside: The intracellular lifestyle of cytosolic bacteria. Nat. Rev. Microbiol. 7, 333-340 (2009).
8. Appelberg R. Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 79, 1117-1128 (2006
9. Hammer ND, Skaar EP. The impact of metal sequestration on Staphylococcus aureus metabolism. Curr. Opin. Microbiol. 15, 10-14 (2012).
10. Meibom KL, Charbit A. Francisella tularensis metabolism and its relation to virulence. Front. Microbiol. 1, 140 (2010).
11. Knodler LA, Celli J. Eating the strangers within: Host control of intracellular bacteria via xenophagy. Cell. Microbiol. 13, 1319-1327 (2011).
12. Ligeon LA, Temime-Smaali N, Lafont F. Ubiquitylation and autophagy in the control of bacterial infections and related inflammatory responses. Cell. Microbiol. 13, 1303-1311 (2011).
13. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl Acad. Sci. USA 103, 14578-14583 (2006
14. Henry T, Monack DM. Activation of the inflammasome upon Francisella tularensis infection: Interplay of innate immune pathways and virulence factors. Cell. Microbiol. 9, 2543-2551 (2007).
15. Meibom KL, Charbit A. The unraveling panoply of Francisella tularensis virulence attributes. Curr. Opin. Microbiol. 13, 11-17 (2010).
16. Asare R, Kwaik YA. Exploitation of host cell biology and evasion of immunity by Francisella tularensis. Front. Microbiol. 1, 145 (2010).
17. Jones JW, Broz P, Monack DM. Innate immune recognition of Francisella tularensis: Activation of type-I interferons and the inflammasome. Front. Microbiol. 2, 16 (2011
18. Pierini R, Juruj C, Perret M et al. AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. Cell Death Differ. 19(10), 1709-1721 (2012).
19. Natale P, Bruser T, Driessen AJ. Sec- And Tat-mediated protein secretion across the bacterial cytoplasmic membrane - distinct translocases and mechanisms. Biochim. Biophys. Acta 1778, 1735-1756 (2008).
20. Desvaux M, Hebraud M, Talon R, Henderson IR. Secretion and subcellular localizations of bacterial proteins: A semantic awareness issue. Trends Microbiol. 17, 139-145 (2009).
21. Forsberg A, Guina T. Type II secretion and type IV pili of Francisella. Ann. NY Acad. Sci. 1105, 187-201 (2007
22. Chandler JC, Molins CR, Petersen JM, Belisle JT. Differential chitinase activity and production within Francisella species, subspecies, and subpopulations. J. Bacteriol. 193, 3265-3275 (2011).
23. Thanassi DG, Bliska JB, Christie PJ. Surface organelles assembled by secretion systems of Gram-negative bacteria: Diversity in structure and function. FEMS Microbiol. Rev. doi:10.1111/j.1574-6976.2012.00342.x (2012) (Epub ahead of print).
24. Schwarz S, Hood RD, Mougous JD. What is type VI secretion doing in all those bugs? Trends Microbiol. 18, 531-537 (2010).
25. Titball RW, Petrosino JF. Francisella tularensis genomics and proteomics. Ann. NY Acad. Sci. 1105, 98-121 (2007).
26. Champion MD, Zeng Q, Nix EB et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. Plos Pathog. 5, e1000459 (2009).
27. Holland IB, Schmitt L, Young J. Type 1 protein secretion in bacteria, the ABCtransporter dependent pathway (review). Mol. Membr. Biol. 22, 29-39 (2005).
28. Eicher T, Cha HJ, Seeger MA et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc. Natl Acad. Sci. USA 109, 5687-5692 (2012).
29. Gil H, Platz GJ, Forestal CA et al. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc. Natl Acad. Sci. USA 103, 12897-12902 (2006).
30. Platz GJ, Bublitz DC, Mena P et al. A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells. Infect. Immun. 78, 1022-1031 (2010).
31. Kadzhaev K, Zingmark C, Golovliov I et al. Identification of genes contributing to the virulence of Francisella tularensis SCHU S4 in a mouse intradermal infection model. Plos One 4, e5463 (2009).
32. Chen I, Dubnau D. DNA uptake during bacterial transformation. Nat. Rev. Microbiol. 2, 241-249 (2004).
33. Ayers M, Howell PL, Burrows LL. Architecture of the type II secretion and type IV pilus machineries. Future Microbiol. 5, 1203-1218 (2010).
34. Chakraborty S, Monfett M, Maier TM et al. Type IV pili in Francisella tularensis: Roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infect. Immun. 76, 2852-2861 (2008).
35. Zogaj X, Chakraborty S, Liu J, Thanassi DG, Klose KE. Characterization of the Francisella tularensis subsp. novicida type IV pilus. Microbiology 154, 2139-2150 (2008).
36. Ark NM, Mann BJ. Impact of Francisella tularensis pilin homologs on pilus formation and virulence. Microb. Pathog. 51, 110-120 (2011).
37. Konecna K, Hernychova L, Reichelova M et al. Comparative proteomic profiling of culture filtrate proteins of less and highly virulent Francisella tularensis strains. Proteomics 10, 4501-4511 (2010).
38. Forslund AL, Salomonsson EN, Golovliov I et al. The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis. BMC Microbiol. 10, 227 (2010).
39. Forslund AL, Kuoppa K, Svensson K et al. Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol. Microbiol. 59, 1818-1830 (2006).
40. Cascales E. The type VI secretion toolkit. EMBO Rep. 9, 735-741 (2008).
41. Pukatzki S, McAuley SB, Miyata ST. The type VI secretion system: Translocation of effectors and effector-domains. Curr. Opin. Microbiol. 12, 11-17 (2009).
42. Miyata ST, Kitaoka M, Wieteska L et al. The Vibrio cholerae type VI secretion system: Evaluating its role in the human disease cholera. Front. Microbiol. 1, 117 (2010).
43. Filloux A. Protein secretion systems in Pseudomonas aeruginosa: An essay on diversity, evolution, and function. Front. Microbiol. 2, 155 (2011
44. Bonemann G, Pietrosiuk A, Mogk A. Tubules and donuts: A type VI secretion story. Mol. Microbiol. 76, 815-821 (2010).
45. Schwarz S, West TE, Boyer F et al. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. Plos Pathog. 6, e1001068 (2010).
46. Russell AB, Hood RD, Bui NK et al. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475, 343-347 (2011).
47. Nano FE, Schmerk C. The Francisella pathogenicity island. Ann. NY Acad. Sci. 1105, 122-137 (2007).
48. Broms JE, Meyer L, Lavander M, Larsson P, Sjostedt A. DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity. Plos One 7, e34639 (2012).
49. Bröms JE, Sjöstedt A, Lavander M. The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Front. Microbiol. 1, 136 (2010).
50. de Bruin OM, Duplantis BN, Ludu JS et al. The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins, IglA, IglB, IglC, PdpB and DotU, suggest roles in type VI secretion. Microbiology 157, 3483-3491 (2011).
51. Golovliov I, Ericsson M, Sandstrom G, Tarnvik A, Sjostedt A. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect. Immun. 65, 2183-2189 (1997
52. Ludu JS, de Bruin OM, Duplantis BN et al. The Francisella pathogenicity island protein PdpD is required for full virulence and associates with homologues of the type VI secretion system. J. Bacteriol. 190, 4584-4595 (2008).
53. Barker JR, Chong A, Wehrly TD et al. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74, 1459-1470 (2009).
54. Deatherage BL, Cookson BT. Membrane vesicle release in bacteria, eukaryotes, and archaea: A conserved yet underappreciated aspect of microbial life. Infect. Immun. 80, 1948-1957 (2012).
55. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64, 163-184 (2010
56. Pierson T, Matrakas D, Taylor YU et al. Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine. J. Proteome Res. 10, 954-967 (2011).
57. Lee BY, Horwitz MA, Clemens DL. Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis. Infect. Immun. 74, 4002-4013 (2006).
58. Lindgren H, Shen H, Zingmark C et al. Resistance of Francisella strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect. Immun. 75, 1303-1309 (2007).
59. Melillo AA, Bakshi CS, Melendez JA. Francisella tularensis antioxidants harness reactive oxygen species to restrict macrophage signaling and cytokine production. J. Biol. Chem. 285, 27553-27560 (2010).
60. Huntley JF, Conley PG, Hagman KE, Norgard MV. Characterization of Francisella tularensis outer membrane proteins. J. Bacteriol. 189, 561-574 (2007).
61. Mohapatra NP, Soni S, Reilly TJ et al. Combined deletion of four Francisella novicida acid phosphatases attenuates virulence and macrophage vacuolar escape. Infect. Immun. 76, 3690-3699 (2008).
62. Mohapatra NP, Soni S, Rajaram MV et al. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J. Immunol. 184, 5141-5150 (2010).
63. Felts RL, Reilly TJ, Tanner JJ. Structure of Francisella tularensis AcpA: Prototype of a unique superfamily of acid phosphatases and phospholipases C. J. Biol. Chem. 281, 30289-30298 (2006).
64. Mohapatra N, Balagopal A, Soni S, Schlesinger L, Gunn J. AcpA is a Francisella acid phosphatase that affects intramacrophage survival and virulence. Infect. Immun. 75, 390-396 (2007).
65. Dai S, Mohapatra NP, Schlesinger LS, Gunn JS. The acid phosphatase AcpA is secreted in vitro and in macrophages by Francisella spp. Infect. Immun. 80, 1088-1097 (2012
66. Child R, Wehrly TD, Rockx-Brouwer D, Dorward DW, Celli J. Acid phosphatases do not contribute to the pathogenesis of type A Francisella tularensis. Infect. Immun. 78, 59-67 (2010).
67. McCaffrey RL, Schwartz JT, Lindemann SR et al. Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis. J. Leukoc. Biol. 88, 791-805 (2010).
68. Gunn JS, Ernst RK. The structure and function of Francisella lipopolysaccharide. Ann. NY Acad. Sci. 1105, 202-218 (2007).
69. Raetz CR, Guan Z, Ingram BO et al. Discovery of new biosynthetic pathways: The lipid A story. J. Lipid Res. 50(Suppl.), S103-S108 (2009
70. Soni S, Ernst RK, Muszynski A et al. Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide O-antigen, core and lipid a and affects intramacrophage survival and vaccine efficacy. Front. Microbiol. 1, 129 (2010).
71. Lindemann SR, Peng K, Long ME et al. Francisella tularensis SCHU S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79, 581-594 (2011).
72. Peng K, Broz P, Jones J, Joubert LM, Monack D. Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis. Cell. Microbiol. 13, 1586-1600 (2011).
73. Clemens DL, Lee BY, Horwitz MA. O-antigen-deficient Francisella tularensis live vaccine strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages. Infect. Immun. 80, 952-967 (2012).
74. Li Y, Powell DA, Shaffer SA et al. LPS remodeling is an evolved survival strategy for bacteria. Proc. Natl Acad. Sci. USA 109, 8716-8721 (2012).
75. Beasley AS, Cotter RJ, Vogel SN et al. A variety of novel lipid A structures obtained from Francisella tularensis live vaccine strain. Innate Immun. 18, 268-278 (2012).
76. Zarrella TM, Singh A, Bitsaktsis C et al. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. Plos One 6, e22335 (2011).
77. Apicella MA, Post DM, Fowler AC et al. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. Plos One 5, e11060 (2010).
78. Bandara AB, Champion AE, Wang X et al. Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice. Plos One 6, e19003 (2011).
79. Su J, Asare R, Yang J et al. The capBCA locus is required for intracellular growth of Francisella tularensis LVS. Front. Microbiol. 2, 83 (2011).
80. Candela T, Fouet A. Poly-g-glutamate in bacteria. Mol. Microbiol. 60, 1091-1098 (2006).
81. Raynaud C, Meibom KL, Lety MA et al. Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect. Immun. 75, 536-541 (2007).
82. Jia Q, Lee BY, Bowen R et al. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Infect. Immun. 78, 4341-4355 (2010).
83. Michell SL, Dean RE, Eyles JE et al. Deletion of the Bacillus anthracis capB homologue in Francisella tularensis subspecies tularensis generates an attenuated strain that protects mice against virulent tularaemia. J. Med. Microbiol. 59, 1275-1284 (2010).
84. Weiss DS, Brotcke A, Henry T et al. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl Acad. Sci. USA 104, 6037-6042 (2007
85. Kraemer PS, Mitchell A, Pelletier MR et al. Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice. Infect. Immun. 77, 232-244 (2009).
86. Moule MG, Monack DM, Schneider DS. Reciprocal analysis of Francisella novicida infections of a Drosophila melanogaster model reveal host-pathogen conflicts mediated by reactive oxygen and imd-regulated innate immune response. Plos Pathog. 6, e1001065 (2010).
87. Straskova A, Pavkova I, Link M et al. Proteome analysis of an attenuated Francisella tularensis dsbA mutant: Identification of potential DsbA substrate proteins. J. Proteome Res. 8, 5336-5346 (2009).
88. Qin A, Scott DW, Rabideau MM, Moore EA, Mann BJ. Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis. Plos One 6, e24611 (2011).
89. Thomas RM, Twine SM, Fulton KM et al. Glycosylation of DsbA in Francisella tularensis subsp. tularensis. J. Bacteriol. 193, 5498-5509 (2011).
90. Balonova L, Mann BF, Cerveny L et al. Characterization of protein glycosylation in Francisella tularensis subsp. holarctica; identification of a novel glycosylated lipoprotein required for virulence. Mol. Cell Proteomics 11, M111.015016 (2012).
91. Ramakrishnan G, Sen B, Johnson R. Paralogous outer membrane proteins mediate uptake of different forms of iron and synergistically govern virulence in Francisella tularensis tularensis. J. Biol. Chem. 287, 25191-25202 (2012).
92. Nallaparaju KC, Yu JJ, Rodriguez SA et al. Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C. Plos One 6, e18201 (2011).
93. Sanapala S, Yu JJ, Murthy AK et al. Perforin- And granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida DfopC vaccine strain. Infect. Immun. 80, 2177-2185 (2012).
94. Jones CL, Sampson TR, Nakaya HI, Pulendran B, Weiss DS. Repression of bacterial lipoprotein production by F. novicida facilitates evasion of innate immune recognition. Cell. Microbiol. 14(10), 1531-1543 (2012).
95. Jones CL, Napier BA, Sampson TR et al. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76(2), 383-404 (2012).
96. Eisenreich W, Dandekar T, Heesemann J, Goebel W. Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat. Rev. Microbiol. 8, 401-412 (2010
97. Krewulak KD, Vogel HJ. Structural biology of bacterial iron uptake. Biochim. Biophys. Acta 1778, 1781-1804 (2008).
98. Hammer ND, Skaar EP. Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu. Rev. Microbiol. 65, 129-147 (2011).
99. Sullivan JT, Jeffery EF, Shannon JD, Ramakrishnan G. Characterization of the siderophore of Francisella tularensis and role of fslA in siderophore production. J. Bacteriol. 188, 3785-3795 (2006).
100. Noinaj N, Guillier M, Barnard TJ, Buchanan SK. TonB-dependent transporters: Regulation, structure, and function. Annu. Rev. Microbiol. 64, 43-60 (2010).
101. Deng K, Blick RJ, Liu W, Hansen EJ. Identification of Francisella tularensis genes affected by iron limitation. Infect. Immun. 74, 4224-4236 (2006).
102. Ramakrishnan G, Meeker A, Dragulev B. fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis SCHU S4. J. Bacteriol. 190, 5353-5361 (2008).
103. Lindgren H, Honn M, Golovlev I et al. The 58-kilodalton major virulence factor of Francisella tularensis is required for efficient utilization of iron. Infect. Immun. 77, 4429-4436 (2009).
104. Sen B, Meeker A, Ramakrishnan G. The fslE homolog, FTL-0439 (fupA/B), mediates siderophore-dependent iron uptake in Francisella tularensis LVS. Infect. Immun. 78, 4276-4285 (2010).
105. Pechous RD, McCarthy TR, Zahrt TC. Working toward the future: Insights into Francisella tularensis pathogenesis and vaccine development. Microbiol. Mol. Biol. Rev. 73, 684-711 (2009).
106. Bina XR, Lavine CL, Miller MA, Bina JE. The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol. Lett. 279, 226-233 (2008).
107. Qin A, Scott DW, Mann BJ. Francisella tularensis subsp. tularensis SCHU S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect. Immun. 76, 3086-3092 (2008).
108. Tsukazaki T, Mori H, Echizen Y et al. Structure and function of a membrane component SecDF that enhances protein export. Nature 474, 235-238 (2011).
109. Llewellyn AC, Jones CL, Napier BA, Bina JE, Weiss DS. Macrophage replication screen identifies a novel Francisella hydroperoxide resistance protein involved in virulence. Plos One 6, e24201 (2011).
110. Huang MT, Mortensen BL, Taxman DJ et al. Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis. J. Immunol. 185, 5476-5485 (2010).
111. Mortensen BL, Fuller JR, Taft-Benz S, Collins EJ, Kawula TH. Francisella tularensis RipA protein topology and identification of functional domains. J. Bacteriol. 194, 1474-1484 (2012).
112. Meibom KL, Barel M, Charbit A. Loops and networks in control of Francisella tularensis virulence. Future Microbiol. 4, 713-729 (2009).
113. Dai S, Mohapatra NP, Schlesinger LS, Gunn JS. Regulation of Francisella tularensis virulence. Front. Microbiol. 1, 144 (2010).
114. Charity JC, Blalock LT, Costante-Hamm MM, Kasper DL, Dove SL. Small molecule control of virulence gene expression in Francisella tularensis. Plos Pathog. 5, e1000641 (2009).